The document discusses telehealth, telemedicine, and reimbursement in the US pre- and post-pandemic. It notes that historically Medicare limited telemedicine but expanded coverage significantly during the pandemic. It explores ongoing debates around permanent expansions, differences between telehealth and telemedicine, employer adoption challenges, and compliance issues. Deployment structures like contracting through wellness programs are examined. Reimbursement changes during the pandemic and proposals for the future are summarized, including defining "reasonable and necessary" coverage and considering commercial insurance coverage.